| ASSET | YEAR | % RETURN |
|---|---|---|
Pfizer (PFE) | 1995 | 72.45% |
Pfizer (PFE) | 1996 | 35.06% |
Pfizer (PFE) | 1997 | 81.92% |
Pfizer (PFE) | 1998 | 66.96% |
Pfizer (PFE) | 1999 | -22.62% |
Pfizer (PFE) | 2000 | 44.73% |
Pfizer (PFE) | 2001 | -11.63% |
Pfizer (PFE) | 2002 | -22.16% |
Pfizer (PFE) | 2003 | 17.1% |
Pfizer (PFE) | 2004 | -22.52% |
Pfizer (PFE) | 2005 | -12% |
Pfizer (PFE) | 2006 | 13.65% |
Pfizer (PFE) | 2007 | -9.01% |
Pfizer (PFE) | 2008 | -17.07% |
Pfizer (PFE) | 2009 | 7.17% |
Pfizer (PFE) | 2010 | -0.12% |
Pfizer (PFE) | 2011 | 27.4% |
Pfizer (PFE) | 2012 | 19.21% |
Pfizer (PFE) | 2013 | 23.98% |
Pfizer (PFE) | 2014 | 5.83% |
Pfizer (PFE) | 2015 | 6.68% |
Pfizer (PFE) | 2016 | 5.83% |
Pfizer (PFE) | 2017 | 15.12% |
Pfizer (PFE) | 2018 | 24.27% |
Pfizer (PFE) | 2019 | -5.76% |
